HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.

AbstractBACKGROUND:
Enhancer of zeste homolog 2 is a component of the Polycomb repressive complex 2 that mediates chromatin-based gene silencing through trimethylation of lysine 27 on histone H3. This complex plays vital roles in the regulation of development-specific gene expression.
DESIGN AND METHODS:
In this study, a comparative microarray analysis of gene expression in primary adult T-cell leukemia/lymphoma samples was performed, and the results were evaluated for their oncogenic and clinical significance.
RESULTS:
Significantly higher levels of Enhancer of zeste homolog 2 and RING1 and YY1 binding protein transcripts with enhanced levels of trimethylation of lysine 27 on histone H3 were found in adult T-cell leukemia/lymphoma cells compared with those in normal CD4(+) T cells. Furthermore, there was an inverse correlation between the expression level of Enhancer of zeste homolog 2 and that of miR-101 or miR-128a, suggesting that the altered expression of the latter miRNAs accounts for the overexpression of the former. Patients with high Enhancer of zeste homolog 2 or RING1 and YY1 binding protein transcripts had a significantly worse prognosis than those without it, indicating a possible role of these genes in the oncogenesis and progression of this disease. Indeed, adult T-cell leukemia/lymphoma cells were sensitive to a histone methylation inhibitor, 3-deazaneplanocin A. Furthermore, 3-deazaneplanocin A and histone deacetylase inhibitor panobinostat showed a synergistic effect in killing the cells.
CONCLUSIONS:
These findings reveal that adult T-cell leukemia/lymphoma cells have deregulated Polycomb repressive complex 2 with over-expressed Enhancer of zeste homolog 2, and that there is the possibility of a new therapeutic strategy targeting histone methylation in this disease.
AuthorsDaisuke Sasaki, Yoshitaka Imaizumi, Hiroo Hasegawa, Akemi Osaka, Kunihiro Tsukasaki, Young Lim Choi, Hiroyuki Mano, Victor E Marquez, Tomayoshi Hayashi, Katsunori Yanagihara, Yuji Moriwaki, Yasushi Miyazaki, Shimeru Kamihira, Yasuaki Yamada
JournalHaematologica (Haematologica) Vol. 96 Issue 5 Pg. 712-9 (May 2011) ISSN: 1592-8721 [Electronic] Italy
PMID21228036 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Histones
  • Hydroxamic Acids
  • Indoles
  • Intracellular Signaling Peptides and Proteins
  • MIRN101 microRNA, human
  • MIRN128 microRNA, human
  • MicroRNAs
  • RYBP protein, human
  • Repressor Proteins
  • Transcription Factors
  • 3-deazaneplanocin
  • Panobinostat
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein
  • Polycomb Repressive Complex 2
  • Polycomb Repressive Complex 1
  • RING1 protein, human
  • Lysine
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, pharmacology)
  • Base Sequence
  • Blotting, Western
  • CD4-Positive T-Lymphocytes (drug effects, metabolism)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • DNA-Binding Proteins (genetics, metabolism)
  • Enhancer of Zeste Homolog 2 Protein
  • Epigenomics
  • Gene Expression Profiling
  • Gene Expression Regulation, Leukemic
  • Histones (metabolism)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Indoles
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Leukemia-Lymphoma, Adult T-Cell (genetics, metabolism, pathology)
  • Lysine (metabolism)
  • Methylation (drug effects)
  • MicroRNAs (genetics)
  • Oligonucleotide Array Sequence Analysis
  • Panobinostat
  • Polycomb Repressive Complex 1
  • Polycomb Repressive Complex 2
  • Repressor Proteins
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: